eyepio

Biopol Chemicals IPO

Biopol Chemicals Limited · Specialty Chemicals

ListedSMENSE EmergeBook builtFresh issue only
Issue price
₹108per share
Issue size
₹31.26 Cr28,94,400 shares
Face value
₹10per equity share
Lot size
2,400 sharesMin. ₹2.59 L at the upper price
  1. Opens
    Fri, 2026
  2. Closes
    Tue, 2026
  3. Allotment
    Wed, 2026
    Refunds same day
  4. Listing
    Fri, 2026

Dates marked in the offer document as tentative. Times in IST.

Information only, not investment advice. This page provides information compiled from official offer documents for information purposes only. It is not investment advice or a recommendation to apply for, buy or sell any security. We are not a SEBI-registered investment adviser or research analyst. Investments in IPOs are subject to market risks; read the offer document carefully before investing.

Issue details

Issue type
Book built, fresh issue
Fresh issue
28,94,400 shares (₹31.26 Cr)
Offer for sale
None
Total issue
28,94,400 shares (₹31.26 Cr)
Market maker portion
1,51,200 shares
Face value
₹10
Listing at
NSE Emerge
Promoter holding
89.89% → 65.81%

Source: ProspectusUpdated

Reservation

Share of the total issue
  • NII37.8%
  • Retail33.3%
  • QIB23.7%
  • Market maker5.2%
CategorySharesOf net offerStated in RHP
Retail individual investors9,62,40035.08%35%
Non-institutional investors (NII)10,94,40039.90%15%
Qualified institutional buyers (QIB)6,86,40025.02%50%
Market maker1,51,200——

Source: ProspectusUpdated

Lot size

Amounts at ₹108 per share
CategoryLotsSharesAmount
Retail individual investors22,400₹2.59 L
Small NII (₹2–10 lakh)33,600₹3.89 L

Source: ProspectusUpdated

Subscription

Category-wise subscription is published by the exchanges while the issue is open. It appears here once the figures are added.

Valuation

FY 2024-25, pre-issue
EPS (basic)
₹5.47
P/E (FY 2024-25 at cap price)
19.74×
RoNW
32.00%
NAV per share
₹17.1
NAV per share (After issue at cap price)
₹41.45
Debt to equity
0.57
EBITDA margin
13.30%
PAT margin
8.81%

Source: ProspectusUpdated

Financials

Consolidated, restated · ₹ crore
RevenueProfit after tax
Period ended31 Dec 20259 months31 Mar 2025FY 2024-2531 Mar 2024FY 2023-2431 Mar 2023FY 2022-23
Revenue from operations48.8449.1325.4719.32
Total income48.9749.1525.4719.33
EBITDA8.996.534.431.56
Profit after tax6.004.332.960.53
Net worth19.5413.539.201.79
Reserves and surplus11.635.621.29—
Total assets48.8831.4817.5612.43
Total borrowing14.927.693.586.69

FY 2024-25 vs FY 2023-24: revenue +92.9%, profit after tax +46.2%. Periods shorter than 12 months are shown as reported and are not annualised.

Source: ProspectusUpdated

About the company

The company trades, manufactures and distributes specialty chemicals in four families: silicones, emulsifiers, biochemicals and polyelectrolytes. It sells mainly to institutional buyers on a business-to-business basis through direct sales and distributors, and also offers technical consultancy to customers. Its manufacturing unit is in West Bengal and its registered office is in Gujarat.

Incorporated
2023
Industry
Specialty Chemicals
CIN
U20297GJ2023PLC140117

Source: ProspectusUpdated

Promoters and shareholders

NameBefore issueAfter issue
Mr. Santanu Sarkar87.61%64.14%
Mr. Vedant Sarkar2.28%1.67%

Source: ProspectusUpdated

Objects of the issue

₹ crore
PurposeAmount
Acquisition of industrial land in Gujarat12.26
Repayment or prepayment of bank, financial institution and NBFC borrowings11.10
General corporate purposes4.04

Source: ProspectusUpdated

Peer comparison

As listed in the offer document
CompanyEPSP/ERoNWNAV per share
Biopol Chemicals LimitedIssuer₹5.4719.74×32.00%₹17.1
Rossari Biotech Limited₹24.6322.18×15.62%₹194.56
Fineotex Chemical Limited₹9.442.58×19.31%₹54.93
Indian Emulsifiers Limited₹10.887.17×20.01%₹91.04

Source: ProspectusUpdated

Strengths and risks

Our summary of what the offer document states

Strengths

  • Product range of 66 specialty chemicals across silicones, emulsifiers, biochemicals and polyelectrolytes.
  • Manufacturing facility holds ISO 9001, ISO 14001 and ISO 45001 certifications, and 42 products have ZDHC Level 3 certification.
  • Revenue and profit grew strongly over FY 2022-23 to FY 2024-25 and the period to December 31, 2025.
  • Confirmed purchase orders of about ₹1,330.85 lakhs as on January 16, 2026, against a manufacturing unit running at high utilisation.
  • Promoter Mr. Santanu Sarkar has over 20 years of experience in the chemicals manufacturing business.

Risks

  • A large share of revenue comes from the textile sector, so a downturn there would affect the business.
  • Revenue is concentrated in West Bengal, Gujarat and Bangladesh.
  • Raw material purchases depend on a limited number of suppliers.
  • Some distributors have no long-term agreements with the company.
  • The land acquisition and debt repayment depend on timelines and terms that are not yet binding with lenders, and the land payment is due by February 15, 2026.

Source: ProspectusUpdated

Contacts

Company
Biopol Chemicals Limited
investors@biopolchemicals.com
+91- 9147076778

Source: ProspectusUpdated

Allotment status

Check whether shares were allotted on the official pages below, using your PAN, application number or DP/client ID. Results appear once the basis of allotment is finalised.

Allotment
Refunds
Demat credit
Listing

Source: ProspectusUpdated

After listing

Listing price, day-one high and low, and the change from the issue price (₹108) appear here after the shares list on NSE Emerge.

Work out the gain or loss on allotted shares after charges and tax →

Frequently asked questions

When does the Biopol Chemicals IPO open and close?

According to the Prospectus, the issue opens on Friday, 6 February 2026 and closes on Tuesday, 10 February 2026.

What is the Biopol Chemicals IPO price band?

The final issue price is ₹108 per share.

What is the lot size of the Biopol Chemicals IPO?

One lot is 2,400 shares, which is ₹2.59 L at ₹108 per share.

Where will Biopol Chemicals shares list?

On NSE Emerge. The tentative listing date is Friday, 13 February 2026.

Who is the registrar of the issue?

Bigshare Services Private Limited (SEBI registration INR000001385). Allotment status is checked on the registrar's website.

How do I check the Biopol Chemicals IPO allotment status?

The basis of allotment is expected to be finalised on Wednesday, 11 February 2026. After that, search by PAN, application number or DP/client ID on the registrar's website (Bigshare Services Private Limited). Shares that are allotted are credited to your demat account; for an application that is not allotted, the blocked amount is released.

How will the money raised be used?

₹12.26 Cr for acquisition of industrial land in Gujarat, ₹11.1 Cr for repayment or prepayment of bank, financial institution and NBFC borrowings, ₹4.04 Cr for general corporate purposes.

Spotted something wrong?

Our data comes from official offer documents, but mistakes can slip through. Report an error and tell us which figure looks wrong and where you saw the correct one (the offer-document page number helps). For anything else, see Contact.